Novartis AG

Pharmaceuticals
Switzerland
Executive 1Mr. Joseph Jimenez, Chief Executive Officer; | Chief Executive Officer;
Executive 2Steven Baert, Head; | Vice-Chairman;
Earnings Per Share Growth (%)11.62%
Cost of Goods Sold (US$ Millions)$17,345
Current Liabilities (US$ Millions)$26,973
Total Assets (US$ Millions)$37,561
Long Term Debt (Millions)$13,799
Return on Equity13.83%
Revenue (US$ Millions)$55,025
Total Company Assets$125,387
Revenue Growth (%)-8.59%
Net Income (US$ Millions)$10,280
Earnings Per Share (US$)$4.13
Total Equity (US$ Millions)$70,766
Profit Margin (%)18.68%
Debt To Equity Ratio (%)0.19%
Inventories (Millions)$6,093